Effects of neuropeptide Y on sucrose and ethanol intake and on anxiety-like behavior in high alcohol drinking (HAD) and low alcohol drinking (LAD) rats
- PMID: 12824809
- DOI: 10.1097/01.ALC.0000071929.17974.DA
Effects of neuropeptide Y on sucrose and ethanol intake and on anxiety-like behavior in high alcohol drinking (HAD) and low alcohol drinking (LAD) rats
Abstract
Background: In a previous study, neuropeptide Y (NPY) administered into the lateral ventricles decreased ethanol intake in alcohol-preferring (P) rats but not in alcohol-nonpreferring (NP) or unselected Wistar rats. The purpose of the present investigation is to extend these findings in selectively-bred high-alcohol-drinking (HAD)1 and low-alcohol-drinking (LAD)1 rats by examining the effects of intracerebroventricularly administered NPY on the elevated plus maze test of anxiety and on ethanol and sucrose intake.
Methods: Female HAD1 and LAD1 rats were surgically implanted with cannula into the lateral ventricle. Following recovery, a test of anxiety was conducted in which the rats (n = 12-13/group) received either artificial cerebrospinal fluid (aCSF) or NPY (10 microg) 10 min prior to a 5-min test on an elevated plus maze. Following anxiety testing, 11 HAD and 11 LAD rats were trained to self-administer ethanol (8% w/v), and 5 HAD and 8 LAD rats were trained to self-administer sucrose (2.5%) during daily 2-hr sessions. A within-subject design was used in which the rats were pretreated once a week with aCSF, 5 microg NPY, or 10 microg NPY prior to the drinking sessions.
Results: HAD and LAD rats treated with aCSF did not differ in time spent in open arms of the plus maze. NPY increased time spent on the open arms to similar degrees in both rat lines. HAD rats consumed more ethanol and sucrose than LAD rats. NPY increased sucrose intake in both rat lines. However, the same doses of NPY reduced ethanol intake in HAD but not in LAD rats.
Conclusion: The plus maze results indicated that selective breeding for high and low alcohol preference in the HAD1 and LAD1 rats, respectively, did not yield differences in anxiety-like behavior and in response to the anxiolytic effects of NPY. The increases in sucrose intake were consistent with the known orexigenic effects of NPY. The decreased ethanol intake following NPY administration in HAD rats was similar to previous observations with P rats and is consistent with the hypothesis that ethanol intake and NPY activity may be inversely related.
Similar articles
-
Effect of neuropeptide Y (NPY) on oral ethanol intake in Wistar, alcohol-preferring (P), and -nonpreferring (NP) rats.Alcohol Clin Exp Res. 2001 Mar;25(3):386-90. Alcohol Clin Exp Res. 2001. PMID: 11290849
-
Neuropeptide Y administration into the third ventricle does not increase sucrose or ethanol self-administration but does affect the cortical EEG and increases food intake.Psychopharmacology (Berl). 2002 Mar;160(2):146-54. doi: 10.1007/s00213-001-0950-9. Epub 2002 Jan 10. Psychopharmacology (Berl). 2002. PMID: 11875632
-
Neuropeptide Y reduces oral ethanol intake in alcohol-preferring (P) rats following a period of imposed ethanol abstinence.Alcohol Clin Exp Res. 2003 May;27(5):787-94. doi: 10.1097/01.ALC.0000065723.93234.1D. Alcohol Clin Exp Res. 2003. PMID: 12766623
-
Neuropeptide Y modulation of ethanol intake: effects of ethanol drinking history and genetic background.Peptides. 2007 Feb;28(2):339-44. doi: 10.1016/j.peptides.2006.07.028. Epub 2006 Dec 21. Peptides. 2007. PMID: 17187900 Review.
-
Central neuropeptide Y in anxiety- and stress-related behavior and in ethanol intake.Ann N Y Acad Sci. 2008 Dec;1148:136-40. doi: 10.1196/annals.1410.083. Ann N Y Acad Sci. 2008. PMID: 19120101 Review.
Cited by
-
Neuropeptide Y (NPY) in the central nucleus of the amygdala (CeA) does not affect ethanol-reinforced responding in binge-drinking, nondependent rats.Pharmacol Biochem Behav. 2012 Mar;101(1):8-13. doi: 10.1016/j.pbb.2011.11.008. Epub 2011 Nov 18. Pharmacol Biochem Behav. 2012. PMID: 22120201 Free PMC article.
-
κ opioid regulation of anxiety-like behavior during acute ethanol withdrawal.Pharmacol Biochem Behav. 2012 Jul;102(1):44-7. doi: 10.1016/j.pbb.2012.03.019. Epub 2012 Apr 2. Pharmacol Biochem Behav. 2012. PMID: 22487769 Free PMC article.
-
Neuropeptide Y (NPY) suppresses yohimbine-induced reinstatement of alcohol seeking.Psychopharmacology (Berl). 2010 Feb;208(3):417-26. doi: 10.1007/s00213-009-1741-y. Epub 2009 Dec 10. Psychopharmacology (Berl). 2010. PMID: 20012021
-
Genotypic and sex differences in anxiety-like behavior and alcohol-induced anxiolysis in High Drinking in the Dark selected mice.Alcohol. 2015 Feb;49(1):29-36. doi: 10.1016/j.alcohol.2014.07.022. Epub 2014 Nov 26. Alcohol. 2015. PMID: 25515706 Free PMC article.
-
The Corticotropin Releasing Factor Receptor 1 in Alcohol Use Disorder: Still a Valid Drug Target?Alcohol Clin Exp Res. 2017 Dec;41(12):1986-1999. doi: 10.1111/acer.13507. Epub 2017 Oct 25. Alcohol Clin Exp Res. 2017. PMID: 28940382 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous